Bryan Murray, Dinsmore, Healthcare lawyer

Associate

Website

Organization Profile

Connect

(412) 339-5603

Professional Biography

Bryan focuses his practice on health care law and provides legal counsel to health care industry clients on a range of issues, such as specialty and mail-order pharmacy operations, provider networks and reimbursement, regulatory compliance, contract review and preparation and 340B programming. He has experience analyzing pharmaceutical trade issues affected by state and federal regulatory frameworks, including pharmacy practice acts, the anti-Kickback Statute, the Drug Supply Chain Security Act, the Stark Law and the Health Insurance Probability and Accountability Act. Bryan also develops and implements compliance plans tailored to detect and address instances of non-compliance in areas, including health information privacy, pharmacy dispensing, and fraud, waste and abuse.

More Legal and Business Bylines From Bryan P. Murray

Cosmetic Regulations Get a Facelift - (Posted On Thursday, February 23, 2023)
D.C. District Court Rules HHS Will be in Charge of OPPS Repayments - (Posted On Thursday, January 19, 2023)
CMS Plans to Regulate Pharmacy Benefit Manager DIR Fees - (Posted On Monday, December 27, 2021)
The Death of Chevron? Supreme Court Hears Oral Arguments on Medicare Cuts to 340B Reimbursement - (Posted On Tuesday, December 07, 2021)
DEA Considering Regulation of Telepharmacy Practice - (Posted On Friday, November 19, 2021)
HRSA Refers Six Drug Manufacturers to OIG for Possible 340B-Related Civil Penalties - (Posted On Friday, September 24, 2021)
Medicare Coverage of Innovative Technology Program Breakthrough Devices Delayed - (Posted On Friday, June 11, 2021)
2021 Open Payments (Sunshine Act) Reporting Window Closes March 31 - (Posted On Friday, March 19, 2021)
Interagency Fraud Enforcement Action Highlights Telepharmacy Compliance Risks - (Posted On Wednesday, February 03, 2021)
HHS Freezes Rule Affecting Community Health Center’s 340B Drug Discounts - (Posted On Friday, January 22, 2021)

Healthcare

340 B Drug Pricing

The National Law Review selected Bryan P. Murray of Dinsmore & Shohl as a Go To Thought Leader for his coverage of 340B Drug Pricing. Mr. Murray’s extensive analysis included U.S. HRS 340B COVID-19 resources and regulations, 340B civil penalties, Health and Human Services (HHS) regulatory rules, and more. NLR readers appreciate Mr. Murray’s comprehensive coverage of the topic, making him a go-to source for the latest news on 340B drug pricing.